LATE and potential estrogen-related risk factors collected 30 years earlier: The 90+ Study. Issue 2 (23rd December 2022)

• Record Type: Journal Article
• Authors: Paganini-Hill, Annlia; Montine, Thomas J; Bukhari, Syed A; Corrada, Maria M; Kawas, Claudia H; Sajjadi, S Ahmad
• Is Part Of: Journal of neuropathology and experimental neurology. Volume 82:Issue 2(2023)
• Page Start: 120
• Page End: 126
• Publication Date: 2022-12-23
• Subjects: Estrogen replacement therapy -- LATE -- Menstrual history -- Neuropathologic change -- Reproductive history -- Risk factors -- TDP-43; Neurology -- Diseases -- Periodicals; Neurology -- Diseases -- Physiopathology -- Periodicals; 616.8047
• DOI: 10.1093/jnen/nlac119
• Languages: English
• ISSNs: 0022-3069

Abstract

Abstract: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a recently described neuropathological construct associated with dementia. This study aimed to investigate in an autopsy study, LATE-NC and its associations with potential estrogen-related risk factors collected about 30 years before death. Participants were part of The 90+ Study and had, as part of the Leisure World Cohort Study, provided information on menstrual and reproductive variables and details of use of estrogen replacement therapy (ERT). No menstrual and reproductive variable showed an association with LATE-NC. Use of ERT, especially long-term use (15+ years) and more recent use (within 1 year of completing the questionnaire), was associated with reduced risk. The odds were significantly lower for long-term (0.39, 95% confidence interval [CI]: 0.16–0.95) and recent use (0.39, 95% CI: 0.16–0.91) compared with no use. In conclusion, we found that women who reported long-term ERT in their 50s and 60s had a significantly reduced odds of harboring LATE-NC when they died in the 10th and 11th decades of their lives. Our study adds to the existing literature reporting seemingly protective effect of peri- and postmenopausal ERT against neurodegenerative dementia.